Clinical Trials
39 trialsOrgan-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
STAR-T
Bayer
HCC
CHA University
DELINOR
Pfizer
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Sun Yat-sen University
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Hunan Cancer Hospital
COMET
UNICANCER
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
Hoffmann-La Roche
Argo
Hoffmann-La Roche
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Hoffmann-La Roche
REBECA
Yonsei University
AVACONT
Hoffmann-La Roche
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Hoffmann-La Roche
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Hoffmann-La Roche
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Hoffmann-La Roche
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Hoffmann-La Roche
CIRCUS
Azienda Ospedaliero, Universitaria Pisana
AVALANCHE
Hoffmann-La Roche
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Eastern Cooperative Oncology Group
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Eastern Cooperative Oncology Group
PICASSO
Hoffmann-La Roche
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Hoffmann-La Roche
Bevacizumab in Metastatic Renal Cancer
Hoffmann-La Roche
Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Hoffmann-La Roche
ENCOURAGE
ARCAGY/ GINECO GROUP
CONCERT
Hoffmann-La Roche
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Hoffmann-La Roche
BevaRet
Technische Universität Dresden
Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
Hoffmann-La Roche
Hepatic Monitoring for Pazopanib
GlaxoSmithKline
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
University of Rome Tor Vergata
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
GlaxoSmithKline
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)
GlaxoSmithKline
ANGIOMET
Spanish Lung Cancer Group
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
Stanford University
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana